Skip to main content
Premium Trial:

Request an Annual Quote

John Radak, Paul Landers, Matthew Robin, Carl Severinghaus, Thomas Bachmann

Point-of-care diagnostics maker Quidel announced this week that John Radak has been named CFO of the firm, succeeding Paul Landers. Radak joins Quidel from Invitrogen, where he served as vice president and chief accounting officer since 2003.
 

 
Swiss compounds research company Tecan last month said its board of directors has appointed and  to its group executive committee.
 
Robin will be responsible for the company’s liquid-handling and robotics business, which is currently being managed by CEO Thomas Bachmann. Robin previously was CEO of medical technology company .
 
Severinghaus worked previously with Beckman Coulter and the American Monitor Corporation, and the and has 15 years experience working at Tecan.
 
In his new position he will manage the company’s direct sales organization.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.